वैकल्पिक उत्पाद विश्लेषण
आपकी अनुमति से हम गोपनीयता-सीमित विश्लेषण का उपयोग करके समझते हैं कि कौन-सी शोध यात्राएँ उपयोगी हैं। हम विज्ञापन ट्रैकर या सत्र रिकॉर्डिंग नहीं चलाते। आप यह विकल्प प्राथमिकताओं में बदल सकते हैं। पढ़ें गोपनीयता नीति.
The Estee Lauder Companies Inc.'s published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $33.3B | |
|---|---|---|
| Revenue (ttm) | 15B | |
| Net income (ttm) | 182M | |
| EPS (ttm) | $0.50 | |
| Shares out | 361.8M | |
| P/E (trailing) | 218.4x | |
| P/E (forward) | 29.8x | |
| Dividend | $1.40 (1.28%) | |
| Volume | 2,423,779 | |
| Beta | 1.27 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | 2026-06-30 | Trend |
| Revenue | $17.74B | $15.91B | $15.61B | $14.33B | $15.05B | -4.0% |
| Gross profit | $13.43B | $11.35B | $11.18B | $10.60B | $11.36B | -4.1% |
| Operating income | $3.17B | $1.51B | $970.0M | $-785.0M | $780.0M | -29.6% |
| Net income | $2.39B | $1.01B | $390.0M | $-1.13B | $182.0M | -47.5% |
| EPS (diluted) | $6.55 | $2.79 | $1.08 | $-3.15 | $0.50 | -47.4% |
| EBITDA | $3.93B | $2.40B | $1.98B | $146.0M | $1.65B | -19.5% |
| R&D | $307.0M | $344.0M | $360.0M | $316.0M | — | +1.0% |
| SG&A | $9.89B | $9.58B | $9.62B | $9.46B | $9.69B | -0.5% |
Recent company headlines from major financial publishers.
The modal expected path reflects gradual operational recovery under the Profit Recovery and Growth Plan, with FY2027 net sales growing 4.46% to $15,720M and FY2028 revenue expanding 4.28% to $16,393M. Operating margin normalizes from 5.18% in FY2026 to 9.20% in FY2027 and reaches 13.50% at the forecast horizon. Diluted EPS expands from trough GAAP $0.50 to $3.32 in FY2027 and $3.91 in FY2028. Discounted at an 8.46% WACC and 9.81% cost of equity, the fundamental composite fair value resolves to Fair value $51.63.
Upside optionality materializes if Hainan and Asian travel retail channels restock faster than expected, accelerating China revenue above historical baseline trends while M·A·C and prestige skincare drive mid-single-digit growth in the US. In this scenario, fixed SG&A leverage accelerates operating margin expansion by FY2028, pushing diluted EPS toward the high end of consensus ($4.30) and generating robust annual free cash flow, supporting valuation toward Potential value $69.17.
| Ke ↓ / g → | 2.0% | 2.3% | 2.5% | 2.8% | 3.0% |
|---|---|---|---|---|---|
| 8.8% | $55.8 | $57.0 | $58.2 | $59.6 | $61.1 |
| 9.3% | $52.7 | $53.7 | $54.7 | $55.8 | $57.0 |
| 9.8% | $50.0 | $50.8 | $51.6 | $52.6 | $53.6 |
| 10.3% | $47.5 | $48.2 | $48.9 | $49.7 | $50.6 |
| 10.8% | $45.4 | $45.9 | $46.6 | $47.2 | $48.0 |
Upcoming earnings date and setup when available.
हर महीने प्रकाशित शोध संस्करण की रेटिंग। रेटिंग विश्लेषण की तारीख की कीमत की तुलना उचित मूल्य से करती है; यह इस बात का रिकॉर्ड नहीं है कि आकलन सही निकला या नहीं।
| वर्ष | जन॰ | फ़र॰ | मार्च | अप्रैल | मई | जून | जुल॰ | अग॰ | सित॰ | अक्टू॰ | नव॰ | दिस॰ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
